Traf2- and Nck-interacting kinase inhibitors: a patent review (2008–2024)
Sign Up to like & getrecommendations! Published in 2025 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2025.2548585
Abstract: ABSTRACT Introduction Traf2- and Nck-interacting kinase (TNIK) is a crucial player in various intracellular signaling pathways, including Wnt/β-catenin, cytoskeleton organization, and immune activation. It phosphorylates several key target genes and is widely expressed in different… read more here.
Keywords: oncology; nck interacting; 2008 2024; interacting kinase ... See more keywords